HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coppe, D. Articles by Salzman, E. Search for Related Content PubMed PubMed Citation Articles by Coppe, D. Articles by Salzman, E.

The Journal of Thoracic and Cardiovascular Surgery, Vol 81, 274-278, Copyright © 1981 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass

D Coppe, M Sobel, L Seamans, F Levine and E Salzman

Thirty-four dogs underwent total cardiopulmonary bypass for 1 or 2 hours with a bubble oxygenator and cardiotomy suction. The dogs were divided into three groups: control dogs which received heparin alone, dogs which received prostacyclin (PGI2) and heparin, and dogs which received prostacyclin alone. PGI2 was given as a bolus (6 to 60 microgram) and then as a constant infusion (0.2 to 0.8 microgram/kg/min) in the venous outflow line. The pump flows were equal in the three groups. PGI2 as a bolus led to transient hypotension, and 60 microgram reduced cardiac output temporarily. During cardiopulmonary bypass, dogs treated with prostacyclin and heparin had low mean arterial perfusion pressures which responded to fluid infusion or phenylephrine. After 1 hour of cardiopulmonary bypass and reversal with protamine, dogs treated with prostacyclin and heparin had shorter bleeding times (p < 0.02) and better platelet function than control animals. After 2 hours, they had normal platelet number, but only half showed preservation of platelet function. When heparin was omitted, PGI2 preserved platelet number, but consumption coagulopathy developed, with prolonged prothrombin, partial thromboplastin, and bleeding times and decreased fibrinogen levels. PGI 2 preserves platelet number and function but may cause hypotension, and it cannot replace heparin in cardiopulmonary bypass.

This article has been cited by other articles:

				J. A. Hyde, J. A Chinn, and T. R Graham Platelets and cardiopulmonary bypass Perfusion, December 1, 1998; 13(6): 389 - 407. [PDF]

				D. He and L. Hou Effects of high dose ascorbic acid on haemostasis during and after cardiopulmonary bypass Perfusion, October 1, 1988; 3(4): 281 - 286. [Abstract] [PDF]

				C. Blauth, A. Brady, J. Arnold, J. Brannan, W. Schulenburg, R. Frackowiak, and K. Taylor A double blind clinical trial of Iloprost during cardiopulmonary bypass Perfusion, October 1, 1987; 2(4): 271 - 276. [Abstract] [PDF]

				K. Taylor Review article : Prostacyclin therapy during cardiopulmonary bypass is it beneficial? Perfusion, January 1, 1987; 2(1): 1 - 7. [PDF]